Medline exits all Medline Brand beds in voluntary field action; costs up to $220M vs $60M annual sales

Medline Inc.

Field action initiated Oct 14, 2026 covers homecare, bariatric and long-term care beds plus pendants, accessories, replacement parts and bed-containing order packages.
Affected products posted net sales of about $60M for the 12 months ended June 27, 2026, within the Front Line Care category of the Medline Brand segment.
Estimated costs of up to $220M cover discontinuation, inventory impairment, disposal and customer credits; booked in 2026-2027 and excluded from Adjusted EBITDA.
Medline does not expect a material impact on FY2026 results or the full-year guidance issued Aug 5, 2026; actual customer credits may differ materially.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.